Results for tag: "Indacaterol"

Indacaterol is a long-acting beta-2 agonist (LABA) used in the treatment of chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it relaxes the muscles in the airways, allowing for easier breathing. It is usually taken once a day, and is available in both inhaler and nebulizer forms. Indacaterol is often used in combination with other respiratory drugs, such as corticosteroids, to provide better symptom relief. Indacaterol is a relatively new drug, having been approved by the US Food and Drug Administration in 2011. It is now widely used in the treatment of COPD, and is becoming increasingly popular due to its long-lasting effects. The market for indacaterol is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include GlaxoSmithKline, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more